| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Soleno Therapeutics, Inc. (SLNO) has 9 insiders with recent SEC Form 4 filings, including 45 buys and 10 sells. SLNO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 569.5K | $30.19M | - | |
| CFO | 103.2K | $5.47M | - | |
| Other | 72.3K | $3.83M | - | |
| Other | 67.2K | $3.56M | - | |
| Other | 64.3K | $3.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 25, 2019 | Schuler Jack W45 | 10% Owner | Buy | 2,563,750 | $1.20 | $3,076,500.00 | +47.6% | |
| Oct 25, 2019 | Abingworth LLP | 10% Owner | Buy | 2,300,000 | $1.20 | $2,760,000.00 | +49.3% | |
| Jul 26, 2019 | Feinberg Larry N | 10% Owner | Buy | 57,069 | $2.14 | $122,276.04 | +1.9% | |
| May 20, 2019 | Bioasia Mangement LLC | 10% Owner | Sell | 90,724 | $1.93 | $174,905.64 | -53.5% | |
| May 20, 2019 | Schuler Jack W45 | 10% Owner | Buy | 835,717 | $2.14 | $1,784,559.43 | +4.7% | |
| Mar 14, 2019 | Feinberg Larry N | 10% Owner | Buy | 130,363 | $1.22 | $159,392.36 | +1.8% | |
| Dec 21, 2018 | Schuler Jack W45 | 10% Owner | Buy | 3,031,002 | $1.61 | $4,868,698.51 | +199.5% | |
| Dec 21, 2018 | Sinclair Andrew | Director | Buy | 4,669,272 | $1.60 | $7,470,835.20 | New | |
| Dec 19, 2018 | Feinberg Larry N | 10% Owner | Buy | 1,245,135 | $1.61 | $2,000,060.35 | +51.1% | |
| Sep 13, 2018 | Tp Management VII LLC | 10% Owner | Sell | 22,682 | $2.03 | $46,082.88 | -0.4% |